Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 801 participants.

Also called NCT02643381

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 801 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02643381
Other papers using this trial's data
  • Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial Intensive care medicine, 2022-01 DOI, PubMed 34904190

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02643381. Randomized; no masking; primary purpose treatment. Start 2016-06-06 (actual); primary completion 2020-12-01 (actual). Results posted on 2021-12-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
Acronym
EvK
Condition
Cardiopulmonary Arrest
Condition
Respiratory Arrest
Intervention (Drug)
Etomidate
Intervention (Drug)
Ketamine
Intervention (Procedure)
Emergency Endotracheal Intubation
Intervention (Device)
Mechanical Ventilation
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct02643381
Content hash
43cab0267249269f34c541629a92e72a416acccb1fa0f7ef1639d2bb63178cfc